Hologic, Inc. Announces Grant of Early Termination of Antitrust Waiting Period for Third Wave Technologies, Inc. Tender Offer

Wednesday, June 25, 2008 General News
Email Print This Page Comment bookmark
Font : A-A+

BEDFORD, Mass., June 25 Hologic, Inc.(Nasdaq: HOLX) today announced that the Federal Trade Commission granted earlytermination of the waiting period under the Hart-Scott-Rodino AntitrustImprovements Act of 1976, as amended (the "HSR Act"), on June 24, 2008, inconnection with Hologic's previously announced tender offer for all of theoutstanding shares of the common stock of Third Wave Technologies, Inc.(Nasdaq: TWTI). The early termination of the waiting period under the HSR Actsatisfies the conditions to the tender offer related to the expiration ortermination of any applicable waiting periods under the HSR Act and otherstate and foreign regulatory laws relating to the restraint of trade orlessening of competition. The tender offer remains subject to certain otherconditions described in the Offer to Purchase.

As previously announced, Hologic commenced a Tender Offer on June 18, 2008for all of the outstanding shares of Third Wave common stock for $11.25 pershare in cash. The tender offer is scheduled to expire at 12:00 midnight, NewYork City time, on July 16, 2008.

About Hologic, Inc.

Hologic, Inc. is a leading developer, manufacturer and supplier of premiumdiagnostics, medical imaging systems and surgical products dedicated toserving the healthcare needs of women. Hologic's core business units arefocused on breast health, diagnostics, GYN surgical, and skeletal health.Hologic provides a comprehensive suite of technologies with products formammography and breast biopsy, radiation treatment for early-stage breastcancer, cervical cancer screening, treatment for menorrhagia, osteoporosisassessment, preterm birth risk assessment, and mini C-arm for extremityimaging. For more information visit www.hologic.com.

Additional Information

This description contained herein is neither an offer to purchase nor asolicitation of an offer to sell shares of Third Wave. The tender offer isbeing made pursuant to a Tender Offer Statement and related materials. ThirdWave shareholders are advised to read the Tender Offer Statement and relatedmaterials filed by Hologic with the U.S. Securities and Exchange Commission(the "SEC"). At the time the tender offer commenced, Hologic and Thunder TechCorp. (a wholly- owned subsidiary of Hologic) filed a Tender Offer Statementon Schedule TO containing an Offer to Purchase, the form of the letter oftransmittal and other documents relating to the tender offer, and Third Wavefiled a Solicitation/Recommendation Statement on Schedule 14D-9 with respectto the tender offer. These documents contain important information about thetender offer, including the terms and conditions of the tender offer, andshareholders of Third Wave are urged to read them carefully. Shareholders ofThird Wave are able to obtain a free copy of these documents athttp://www.hologic.com and the website maintained by the SEC athttp://www.sec.gov. In addition, shareholders are able to obtain a free copyof these documents by contacting Hologic or Third Wave.Contact: Glenn P. Muir Executive Vice President & CFO Hologic, Inc. (781) 999-7300 Frances Doria Director, Investor Relations Hologic, Inc. (781) 999-7377

SOURCE Hologic, Inc.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store